{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:56:13Z","timestamp":1791870973593,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.meegid.2024.105679","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:44:24Z","timestamp":1728017064000},"page":"105679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["High HIV-1 genetic diversity and low prevalence of transmitted drug resistance among treatment-naive people living with HIV in Madagascar"],"prefix":"10.1016","volume":"125","author":[{"given":"Fetra Angelot","family":"Rakotomalala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Butel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahinamandranto","family":"Rasamoelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santatriniaina Hajanirina Dauphin","family":"Randriarimanana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Maharavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajanirina Nathanaella","family":"Randriamananjara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fernandez-Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felana Ranaivo","family":"Rabetokotany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Aurore Doll","family":"Rakoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Delaporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Babin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc Herv\u00e9","family":"Samison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Nerrienet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahidjo","family":"Ayouba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2024.105679_bb0005","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2021.38.335.26357","article-title":"Human immunodeficiency virus (HIV) type 1 genetic diversity in HIV positive individuals on antiretroviral therapy in a cross sectional study conducted in Teso, Western Kenya","volume":"38","author":"Adhiambo","year":"2021","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.meegid.2024.105679_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015484","article-title":"Call for action: addressing the alarming surge of HIV in Madagascar","volume":"9","author":"Andrianarimanana-K\u00f6cher","year":"2024","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.meegid.2024.105679_bb0015","author":"ANRS"},{"key":"10.1016\/j.meegid.2024.105679_bb0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/QAI.0000000000002908","article-title":"High level of HIV drug resistance and Virologic nonsuppression among female sex Workers in Ethiopia: a Nationwide cross-sectional study","volume":"89","author":"Arimide","year":"2022","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.meegid.2024.105679_bb0025","series-title":"DEVPORT 2023 Le Havre. Laboratoire IDEES, Universit\u00e9 Le Havre Normandie, Le Havre, France","article-title":"From small ports to large ports: A historical perspective on the hierarchy of ports in Madagascar","author":"Baron","year":"2023"},{"key":"10.1016\/j.meegid.2024.105679_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/COH.0000000000000534","article-title":"HIV subtype diversity worldwide","volume":"14","author":"Bbosa","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.meegid.2024.105679_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dkw463","article-title":"Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis","volume":"72","author":"Boerma","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2024.105679_bb0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3390\/bios13040463","article-title":"Evaluation of DNA extraction methods for reliable quantification of Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa","volume":"13","author":"Bogo\u017ealec Ko\u0161ir","year":"2023","journal-title":"Biosensors"},{"key":"10.1016\/j.meegid.2024.105679_bb0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/v12060645","article-title":"Quality control of next-generation sequencing-based HIV-1 drug resistance data in clinical laboratory information systems framework","volume":"12","author":"Capina","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.meegid.2024.105679_bb0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/infdis\/jiz094","article-title":"Viral diversity based on next-generation sequencing of HIV-1 provides precise estimates of infection Recency and time since infection","volume":"220","author":"Carlisle","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105679_bb0055","doi-asserted-by":"crossref","DOI":"10.2196\/50894","article-title":"Pretreatment HIV drug resistance and the molecular transmission network among HIV-positive individuals in China in 2022: multicenter observational study","volume":"9","author":"Chen","year":"2023","journal-title":"JMIR Public Health Surveill."},{"key":"10.1016\/j.meegid.2024.105679_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.eclinm.2019.03.006","article-title":"Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000-2016: a pooled sequence analysis","volume":"9","author":"Chimukangara","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.meegid.2024.105679_bb0065","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1182\/blood-2010-12-322453","article-title":"Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection","volume":"117","author":"Corbeau","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2024.105679_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261522","article-title":"Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique","volume":"17","author":"Cuco","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2024.105679_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01443-18","article-title":"Limited marginal utility of deep sequencing for HIV drug resistance testing in the age of integrase inhibitors","volume":"56","author":"Dalmat","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2024.105679_bb0080","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/QAI.0b013e3181806c0e","article-title":"High prevalence of unique recombinant forms of HIV-1 in Ghana: molecular epidemiology from an antiretroviral resistance study","volume":"48","author":"Delgado","year":"2008","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.meegid.2024.105679_bb0085","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1186\/s12879-023-08649-3","article-title":"Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017\u20132020","volume":"23","author":"Fiebig","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105679_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(24)00153-X","article-title":"Madagascar urgently needs a 2024 national prevalence survey of HIV","volume":"11","author":"Geoffroy","year":"2024","journal-title":"Lancet HIV"},{"key":"10.1016\/j.meegid.2024.105679_bb0095","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/10635150390235520","article-title":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood","volume":"52","author":"Guindon","year":"2003","journal-title":"Syst. Biol."},{"key":"10.1016\/j.meegid.2024.105679_bb0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105679_bb0105","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/S2352-3018(18)30173-5","article-title":"HIV drug resistance in low-income and middle-income countries","volume":"5","author":"Hamers","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.meegid.2024.105679_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4339-y","article-title":"Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4\u20138weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011\u201312 and 2012\u201313","volume":"19","author":"Hunt","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105679_bb0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/QAD.0000000000001696","article-title":"When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children","volume":"32","author":"Inzaule","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.meegid.2024.105679_bb0120","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/QAD.0000000000002277","article-title":"Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age","volume":"33","author":"Inzaule","year":"2019","journal-title":"AIDS Lond. Engl."},{"key":"10.1016\/j.meegid.2024.105679_bb0125","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/v14091992","article-title":"Molecular epidemiology and trends in HIV-1 transmitted drug resistance in Mozambique 1999\u20132018","volume":"14","author":"Ismael","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.meegid.2024.105679_bb0130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1089\/aid.2020.0242","article-title":"Pretreatment HIV drug resistance among adults initiating or re-initiating first-line antiretroviral therapy in Zimbabwe: fast-tracking the transition to Dolutegravir-based first-line regimens?","volume":"37","author":"Kouamou","year":"2021","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.meegid.2024.105679_bb0135","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","article-title":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected Seroconverters in India, with evidence of Intersubtype recombination","volume":"73","author":"Lole","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2024.105679_bb0140","first-page":"335","article-title":"Prevalence of drug-resistant mutations in newly diagnosed drug-na\u00efve HIV-1-infected individuals in a treatment site in the Waterberg district, Limpopo province","volume":"101","author":"Nwobegahay","year":"2011","journal-title":"South Afr. Med. J. Suid-Afr. Tydskr. Vir Geneeskd."},{"key":"10.1016\/j.meegid.2024.105679_bb0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12985-020-01386-y","article-title":"Transmitted drug resistance mutations and subtype diversity amongst HIV-1 sero-positive voluntary blood donors in Accra, Ghana","volume":"17","author":"Obeng","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.meegid.2024.105679_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203437","article-title":"Hospitalization of HIV positive patients in a referral tertiary care hospital in Antananarivo Madagascar, 2010-2016: trends, causes and outcome","volume":"13","author":"Raberahona","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2024.105679_bb0155","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/aid.2006.22.595","article-title":"High HIV type 1 subtype diversity and few drug resistance mutations among seropositive people detected during the 2005 second generation HIV surveillance in Madagascar","volume":"22","author":"Razafindratsimandresy","year":"2006","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.meegid.2024.105679_bb0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/tropicalmed9010019","article-title":"Patterns of rising HIV positivity in northern Madagascar: evidence of an urgent public health concern","volume":"9","author":"Robinson","year":"2024","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105679_bb0165","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/14737159.8.5.635","article-title":"In-house HIV-1 RNA real-time RT-PCR assays: principle, available tests and usefulness in developing countries","volume":"8","author":"Rouet","year":"2008","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.meegid.2024.105679_bb0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12981-019-0220-8","article-title":"High rates of transmitted NNRTI resistance among persons with acute HIV infection in Malawi: implications for first-line dolutegravir scale-up","volume":"16","author":"Rutstein","year":"2019","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.meegid.2024.105679_bb0175","series-title":"Rapport Sur la Reponse Face au VIH et au SIDA a Madagascar 2014. Madagascar","author":"SE\/CNLS","year":"2014"},{"key":"10.1016\/j.meegid.2024.105679_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28184","article-title":"Prevalence of drug resistant HIV-1 forms in patients without any history of antiretroviral therapy in the Republic of Guinea","volume":"95","author":"Shchemelev","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2024.105679_bb0185","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jix544","article-title":"Prevalence of pre-antiretroviral-treatment drug resistance by gender, age, and other factors in HIV-infected individuals initiating therapy in Kenya, 2013\u20132014","volume":"216","author":"Silverman","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105679_bb0190","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jix544","article-title":"Prevalence of pre-antiretroviral-treatment drug resistance by gender, age, and other factors in HIV-infected individuals initiating therapy in Kenya, 2013\u20132014","volume":"216","author":"Silverman","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2024.105679_bb0195","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/v11090877","article-title":"Prevalence and correlates of pre-treatment HIV drug resistance among HIV-infected children in Ethiopia","volume":"11","author":"Tadesse","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.meegid.2024.105679_bb0200","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/jac\/dky278","article-title":"Pretreatment HIV drug resistance among adults initiating ART in Namibia","volume":"73","author":"Taffa","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2024.105679_bb0205","author":"UNAIDS"},{"key":"10.1016\/j.meegid.2024.105679_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.16.1.18567","article-title":"Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability","volume":"16","author":"Usach","year":"2013","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.meegid.2024.105679_bb0215","author":"USAID"},{"key":"10.1016\/j.meegid.2024.105679_bb0220","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jcv.2010.01.008","article-title":"Viral load assay sensitivity and low level viremia in HAART treated HIV patients","volume":"47","author":"Verhofstede","year":"2010","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.meegid.2024.105679_bb0225","author":"WHO"},{"key":"10.1016\/j.meegid.2024.105679_bb0230","author":"WHO"},{"key":"10.1016\/j.meegid.2024.105679_bb0235","author":"WHO"},{"key":"10.1016\/j.meegid.2024.105679_bb0240","author":"WHO"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134824001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134824001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T10:57:43Z","timestamp":1731409063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134824001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":48,"alternative-id":["S1567134824001308"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2024.105679","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High HIV-1 genetic diversity and low prevalence of transmitted drug resistance among treatment-naive people living with HIV in Madagascar","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2024.105679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105679"}}